| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Diagnostics, T-detect | SVP, Diagnostics, Immunoseq Dx
1 company
Palaniappan Jyoti serves as a SVP, Diagnostics, T-detect at ADPT. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $245K at current prices.
Historically, Palaniappan Jyoti's trades have earned a strong insider score of 83/100 across 6 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +76.8%.
The biggest single holding is ADPT (~$245K) as SVP, Diagnostics, T-detect. The recent filings there lean toward selling, a net 20,607 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2021 | ADPT Adaptive Biotechnologies Corp | SVP, Diagnostics, T-detect | Sale+OE | 651 | $36.12 | $23,514.12 | -6.6% | -13.6% | -75.1% | |
| Jun 18, 2021 | ADPT Adaptive Biotechnologies Corp | SVP, Diagnostics, T-detect | Sale+OE | 1,952 | $39.87 | $77,819.80 | -9.6% | -2.7% | -81.4% | |
| May 18, 2021 | ADPT Adaptive Biotechnologies Corp | SVP, Diagnostics, T-detect | Sale+OE | 651 | $35.00 | $22,785.00 | -6.6% | -12.4% | -78.6% | |
| Apr 19, 2021 | ADPT Adaptive Biotechnologies Corp | SVP, Diagnostics, T-detect | Sale+OE | 1,301 | $41.25 | $53,666.25 | -12.4% | -10.5% | -75.0% | |
| Mar 18, 2021 | ADPT Adaptive Biotechnologies Corp | SVP, Diagnostics, Immunoseq Dx | Sale+OE | 16,052 | $43.58 | $699,560.09 | -30.3% | -8.9% | -69.3% |